Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
A structural systems biology approach for quantifying the systemic consequences of missense mutations in proteins.
|
23093928 |
2012 |
Noonan Syndrome
|
0.770 |
GeneticVariation
|
disease |
CLINVAR |
Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome.
|
18413255 |
2008 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome.
|
18413255 |
2008 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |
Noonan Syndrome
|
0.770 |
GeneticVariation
|
disease |
CLINVAR |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |
Noonan Syndrome
|
0.770 |
Biomarker
|
disease |
CTD_human |
Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.
|
17703371 |
2007 |
Noonan Syndrome
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Cardiofaciocutaneous syndrome (CFCS) is a rare developmental disorder that is phenotypically similar to Noonan syndrome and is associated with mutations in BRAF, MEK1, MEK2, and KRAS.
|
31125963 |
2019 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
|
24451042 |
2014 |
Noonan Syndrome
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis revealed individual heterozygous mutations in the KRAS (phenotype of CFC/Noonan syndrome) and BRAF genes (phenotype of CFC syndrome).
|
21871821 |
2012 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Noonan Syndrome
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Noonan Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Noonan Syndrome
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Germline gain-of-function mutations in RAF1 cause Noonan syndrome.
|
17603482 |
2007 |
Noonan Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
Germline gain-of-function mutations in RAF1 cause Noonan syndrome.
|
17603482 |
2007 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
|
16439621 |
2006 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
|
23026937 |
2013 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
In one patient with NS, we also identified a mutation, BRAF K499E, that has previously been reported in patients with CFC.
|
18456719 |
2008 |
Noonan Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
In one patient with NS, we also identified a mutation, BRAF K499E, that has previously been reported in patients with CFC.
|
18456719 |
2008 |
Noonan Syndrome
|
0.770 |
Biomarker
|
disease |
BEFREE |
Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants.
|
22826437 |
2012 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors.
|
19376813 |
2009 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.
|
16953233 |
2007 |
Noonan Syndrome
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
|
15035987 |
2004 |